dose of 3000 mg (1500 mg twice daily). KEPPRA Oral Solution Weight-Based Dosing Calculation For Pediatric Patients. The following calculation should be used
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Keppra, levetiracetam-AFT. ICU INDICATIONS: Seizures and seizure 500 - 1500 mg BD. Increase to maximum dose 2024 mg BD if needed.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
Immediate-release (Keppra, Spritam): 500 mg IV/PO q12hr; may increase q2week by 500 mg/dose to recommended dose of 1500 mg q12hr.
KEPPRA (1500 mg twice daily) did not alter the pharmacokinetics of valproate in healthy volunteers. 2 mg/kg/day (high dose is equivalent to 2 times the
Adults See Table 1 for the recommended preparation and administration of KEPPRA injection for adults to achieve a dose of 500 mg, 1000 mg, or 1500 mg.
Increase the daily dose every 2 weeks by increments of. 500 mg to a maximum recommended daily dose of 1500 mg (750 mg twice daily). For KEPPRA tablet dosing in
Comments